Jonathan Jackson - 01 Jun 2022 Form 4 Insider Report for Histogen Inc. (HSTO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HSTO	Stock Option (right to buy)	Award	$0	+1,000		$0.000000	1,000	01 Jun 2022	Common Stock	1,000	$3.20	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	On June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 and the exercise price have been adjusted to reflect the Reverse Stock Split.
F2	This option was issued to the Reporting Person, a non-employee director of the Issuer, for his service as a director of the Issuer.
F3	The shares subject to this option become fully vested and exercisable on 6/1/2023, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.